BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 6807538)

  • 1. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies.
    Groopman JD; Haugen A; Goodrich GR; Wogan GN; Harris CC
    Cancer Res; 1982 Aug; 42(8):3120-4. PubMed ID: 6807538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay.
    Haugen A; Groopman JD; Hsu IC; Goodrich GR; Wogan GN; Harris CC
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4124-7. PubMed ID: 6794029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
    Hsieh LL; Hsu SW; Chen DS; Santella RM
    Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of aflatoxin B1 and identification of the major aflatoxin B1-DNA adducts formed in cultured human bronchus and colon.
    Autrup H; Essigmann JM; Croy RG; Trump BF; Wogan GN; Harris CC
    Cancer Res; 1979 Mar; 39(3):694-8. PubMed ID: 427755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays.
    Groopman JD; Trudel LJ; Donahue PR; Marshak-Rothstein A; Wogan GN
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7728-31. PubMed ID: 6440143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro reactions of aflatoxin B1-adducted DNA.
    Groopman JD; Croy RG; Wogan GN
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5445-9. PubMed ID: 6795633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of aflatoxin B1-DNA adducts and in vitro transformation in mouse embryo fibroblasts C3H/10T1 1/2.
    Amstad PA; Wang TV; Cerutti PA
    J Natl Cancer Inst; 1983 Jan; 70(1):135-9. PubMed ID: 6401827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excision repair of aflatoxin B1-DNA adducts in human fibroblasts.
    Leadon SA; Tyrrell RM; Cerutti PA
    Cancer Res; 1981 Dec; 41(12 Pt 1):5125-9. PubMed ID: 6796265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative formation and removal of aflatoxin B1-DNA adducts in cultured mammalian tracheal epithelium.
    Ball RW; Wilson DW; Coulombe RA
    Cancer Res; 1990 Aug; 50(16):4918-22. PubMed ID: 2116221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
    Irvin TR; Wogan GN
    Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of monoclonal antibodies against aflatoxin B1.
    Lu G; Liu B; Liu C; Wang D; Cao M
    Chin J Biotechnol; 1995; 11(4):253-8. PubMed ID: 8739103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of aflatoxin B2a antibody with aflatoxin B1-modified DNA and related metabolites.
    Pestka JJ; Li YK; Chu FS
    Appl Environ Microbiol; 1982 Nov; 44(5):1159-65. PubMed ID: 6817711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis.
    Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM
    Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.
    Croy RG; Wogan GN
    Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
    Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
    Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
    Swenson DH; Lin JK; Miller EC; Miller JA
    Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys.
    Croy RG; Wogan GN
    J Natl Cancer Inst; 1981 Apr; 66(4):761-8. PubMed ID: 6939922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of aflatoxin B1 on DNA enzymatic methylation and secondary structures of the rat liver].
    Aslanian VM; Babaian IuS; Arutiunian SG; Garibzhanian BT; Danielian IS
    Vopr Onkol; 1989; 35(1):48-52. PubMed ID: 2493185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro.
    Wood ML; Smith JR; Garner RC
    Cancer Res; 1988 Oct; 48(19):5391-6. PubMed ID: 3138022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.